| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
76,615 |
66,105 |
$10.90M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
52,858 |
39,983 |
$837K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,868 |
6,285 |
$164K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,871 |
2,708 |
$71K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,058 |
2,055 |
$61K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,426 |
1,424 |
$47K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,026 |
1,024 |
$47K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,257 |
1,257 |
$45K |
| 99215 |
Prolong outpt/office vis |
1,202 |
1,157 |
$42K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,214 |
1,147 |
$36K |
| J3490 |
Unclassified drugs |
492 |
491 |
$30K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
400 |
397 |
$25K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
703 |
699 |
$18K |
| 90677 |
|
376 |
374 |
$15K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
747 |
709 |
$13K |
| 92552 |
|
2,943 |
2,933 |
$13K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
664 |
663 |
$13K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
181 |
179 |
$12K |
| 90686 |
|
1,906 |
1,904 |
$10K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
874 |
844 |
$7K |
| 0072A |
|
98 |
49 |
$5K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
285 |
162 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
148 |
147 |
$4K |
| 87428 |
|
95 |
95 |
$4K |
| 86580 |
|
2,491 |
2,440 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,004 |
991 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,249 |
1,128 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
702 |
347 |
$3K |
| 0071A |
|
58 |
29 |
$3K |
| 85018 |
|
4,971 |
4,937 |
$3K |
| 99188 |
|
296 |
295 |
$3K |
| 99173 |
|
2,957 |
2,954 |
$2K |
| 90715 |
|
480 |
479 |
$2K |
| 90734 |
|
474 |
474 |
$2K |
| 90648 |
|
809 |
804 |
$2K |
| 90716 |
|
658 |
657 |
$2K |
| 90651 |
|
620 |
619 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
831 |
738 |
$2K |
| 90700 |
|
732 |
729 |
$2K |
| 90633 |
|
674 |
672 |
$2K |
| 0064A |
|
31 |
17 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
201 |
199 |
$2K |
| 90707 |
|
665 |
663 |
$1K |
| 81003 |
|
3,242 |
3,135 |
$1K |
| 81025 |
|
1,347 |
1,292 |
$1K |
| 90713 |
|
429 |
427 |
$1K |
| 90680 |
|
301 |
299 |
$874.21 |
| 87400 |
|
484 |
355 |
$771.83 |
| 90723 |
|
309 |
307 |
$603.00 |
| 92228 |
|
52 |
51 |
$426.56 |
| 96127 |
|
133 |
132 |
$370.80 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
174 |
170 |
$235.59 |
| 90746 |
|
26 |
25 |
$211.14 |
| G0466 |
Federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
12 |
12 |
$207.12 |
| 69209 |
|
63 |
56 |
$204.23 |
| 90670 |
|
474 |
470 |
$171.00 |
| 93000 |
|
81 |
80 |
$131.73 |
| 82962 |
|
344 |
341 |
$124.88 |
| D1206 |
Topical application of fluoride varnish |
43 |
43 |
$17.82 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
214 |
193 |
$1.28 |
| 3074F |
|
72 |
71 |
$0.00 |
| 3079F |
|
45 |
44 |
$0.00 |
| 3080F |
|
17 |
15 |
$0.00 |
| 3077F |
|
114 |
107 |
$0.00 |
| 3078F |
|
114 |
108 |
$0.00 |
| 73562 |
|
16 |
12 |
$0.00 |